Evidence map›Paper›PMID 28256580›Full record

ArticleScientific reports2017

PAR1 activation induces rapid changes in glutamate uptake and astrocyte morphology.

Amanda M Sweeney, Kelsey E Fleming, John P McCauley, Marvin F Rodriguez, Elliot T Martin, Alioscka A Sousa, Richard D Leapman, Annalisa Scimemi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Targeting enhancing myelin regeneration reverses cognitive deficits in a mouse model of intellectual disability.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Diversification of PAR signaling through receptor crosstalk.Cellular & molecular biology letters · 2022
    Review
  7. Control of complex behavior by astrocytes and microglia.Neuroscience and biobehavioral reviews · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Blocking the Thrombin Receptor Promotes Repair of Demyelinated Lesions in the Adult Brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Podocalyxin is required for maintaining blood-brain barrier function during acute inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Amanda M SweeneySUNY Albany, Dept. Biology, 1400 Washington Avenue, Albany NY 12222, USA.
Kelsey E FlemingSUNY Albany, Dept. Biology, 1400 Washington Avenue, Albany NY 12222, USA.
John P McCauleySUNY Albany, Dept. Biology, 1400 Washington Avenue, Albany NY 12222, USA.
Marvin F RodriguezSUNY Albany, Dept. Biology, 1400 Washington Avenue, Albany NY 12222, USA.
Elliot T MartinSUNY Albany, Dept. Biology, 1400 Washington Avenue, Albany NY 12222, USA.
Alioscka A SousaNational Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 9000 Rockville Pike, Bethesda MD 20852, USA.
Richard D LeapmanNational Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 9000 Rockville Pike, Bethesda MD 20852, USA.
Annalisa ScimemiSUNY Albany, Dept. Biology, 1400 Washington Avenue, Albany NY 12222, USA.
University at Albany, State University of New York · USNational Institutes of Health · US

Funding

Scanning Transmission Electron Tomography of Biological StructuresZIAEB000046 · NIBIB · NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING · PI LEAPMAN, RICHARD · 2009 to 2025
$13.0M
6 · The paper itself

Abstract

The G-protein coupled, protease-activated receptor 1 (PAR1) is a membrane protein expressed in astrocytes. Fine astrocytic processes are in tight contact with neurons and blood vessels and shape excitatory synaptic transmission due to their abundant expression of glutamate transporters. PAR1 is proteolytically-activated by bloodstream serine proteases also involved in the formation of blood clots. PAR1 activation has been suggested to play a key role in pathological states like thrombosis, hemostasis and inflammation. What remains unclear is whether PAR1 activation also regulates glutamate uptake in astrocytes and how this shapes excitatory synaptic transmission among neurons. Here we show that, in the mouse hippocampus, PAR1 activation induces a rapid structural re-organization of the neuropil surrounding glutamatergic synapses, which is associated with faster clearance of synaptically-released glutamate from the extracellular space. This effect can be recapitulated using realistic 3D Monte Carlo reaction-diffusion simulations, based on axial scanning transmission electron microscopy (STEM) tomography reconstructions of excitatory synapses. The faster glutamate clearance induced by PAR1 activation leads to short- and long-term changes in excitatory synaptic transmission. Together, these findings identify PAR1 as an important regulator of glutamatergic signaling in the hippocampus and a possible target molecule to limit brain damage during hemorrhagic stroke.

Indexed as

AlgorithmsAnimalsAstrocytesBiological TransportFemaleGlutamic AcidHippocampusImaging, Three-DimensionalLong-Term PotentiationMaleMiceModels, BiologicalMonte Carlo MethodNeuronsReceptor, PAR-1Receptors, AMPAGlutamic AcidReceptor, PAR-1Receptors, AMPA

Identifiers

PMID28256580
PMCPMC5335386
OpenAlexW2594166368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.